Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Gruenberger

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Nature Medicine|August 8, 2022
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trialRupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2025
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) StudySebastian Stintzing, Susanne Klein-Scory, Ludwig Fischer von Weikersthal, et al.
Neuro-Oncology|July 4, 2024
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastasesRupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
The British Journal of Surgery|July 13, 2023
Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSEAjith K Siriwardena, Alejandro Serrablo, Åsmund Avdem Fretland, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 20, 2023
The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSEAjith K Siriwardena, Alejandro Serrablo, Åsmund A Fretland, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Nature Medicine|August 8, 2022
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trialRupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2025
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) StudySebastian Stintzing, Susanne Klein-Scory, Ludwig Fischer von Weikersthal, et al.
Neuro-Oncology|July 4, 2024
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastasesRupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
The British Journal of Surgery|July 13, 2023
Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSEAjith K Siriwardena, Alejandro Serrablo, Åsmund Avdem Fretland, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 20, 2023
The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSEAjith K Siriwardena, Alejandro Serrablo, Åsmund A Fretland, et al.
Pageof 4